Final results from the phase Ia/Ib study of the novel bromodomain and extra-terminal domain inhibitor, BI 894999, in patients with advanced solid tumors or diffuse large B-cell lymphoma
新型溴结构域和末端结构域抑制剂 BI 894999 治疗晚期实体瘤或弥漫性大B细胞淋巴瘤患者的 Ia/Ib 期研究的最终结果
期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2025.104499
Lauer, U M; Awada, A; Postel-Vinay, S; Shapiro, G I; Thieblemont, C; Piha-Paul, S A; Paik, P K; Shepard, D R; Docampo, L I; Galot, R; Rottey, S; Sadrolhefazi, B; Marzin, K; Musa, H; Schöffski, P